Beyond just peptide antigens: the complex world of peptide-based cancer vaccines

Beyond just peptide antigens: the complex world of peptide-based cancer vaccines

Peptide-based cancer vaccines rely upon the strong activation of the adaptive immune response to elicit its effector function. They have shown to be highly specific and safe, but have yet to prove themselves as an efficacious treatment for cancer in the clinic. This is for a variety of reasons, incl...

Descripció completa

Dades bibliogràfiques
Autors principals:	Stephens, AJ, Burgess-Brown, NA, Jiang, S
Format:	Journal article
Idioma:	English
Publicat:	Frontiers Media 2021

Ítems similars

Beyond Just Peptide Antigens: The Complex World of Peptide-Based Cancer Vaccines
per: Alexander J. Stephens, et al.
Publicat: (2021-06-01)

Cancer-Testis Antigen Peptide Vaccine for Cancer Immunotherapy: Progress and Prospects
per: Xiao Wei, et al.
Publicat: (2019-05-01)

Adrenomedullin: Not Just Another Gastrointestinal Peptide
per: Sonia Martínez-Herrero, et al.
Publicat: (2022-01-01)

Prevention of EAE by tolerogenic vaccination with PEGylated antigenic peptides
per: Jennifer Pfeil, et al.
Publicat: (2021-08-01)

Peptide Vaccines for Cancer
per: Kono K
Publicat: (2013-10-01)

Peptide-Based Vaccine against SARS-CoV-2: Peptide Antigen Discovery and Screening of Adjuvant Systems
per: Ahmed O. Shalash, et al.
Publicat: (2022-04-01)

Adjuvants for peptide-based cancer vaccines
per: Willem W Overwijk, et al.
Publicat: (2016-09-01)

Peptide-based vaccine for cancer therapies
per: Luigi Buonaguro, et al.
Publicat: (2023-08-01)

Presentation of antigenic peptides by products of the major histocompatibility complex.
per: Fairchild, P
Publicat: (1998)

Developing recombinant overlapping peptides of prostate-specific antigen as vaccine
per: Chan, S
Publicat: (2022)

Role of Linker Length and Antigen Density in Nanoparticle Peptide Vaccine
per: Chintan H. Kapadia, et al.
Publicat: (2019-03-01)

Corrigendum: Peptide-based vaccine for cancer therapies
per: Luigi Buonaguro, et al.
Publicat: (2023-10-01)

Assessment of Crosslinkers between Peptide Antigen and Carrier Protein for Fusion Peptide-Directed Vaccines against HIV-1
per: Li Ou, et al.
Publicat: (2022-11-01)

1379 Novel backbone-modified analogues of antigenic peptides improve immunogenic capabilities of anti-tumor peptide vaccines
per: Douglas McNeel, et al.
Publicat: (2023-11-01)

Low-complexity sequences and single amino acid repeats: not just "junk" peptide sequences.
per: Haerty, W, et al.
Publicat: (2010)

TEIPP peptides: exploration of unTAPped cancer antigens
per: Koen A. Marijt, et al.
Publicat: (2019-08-01)

In vitro evaluation of dual-antigenic PV1 peptide vaccine in head and neck cancer patients
per: San Jiun Chai, et al.
Publicat: (2019-01-01)

Photochemical Internalization of Peptide Antigens Provides a Novel Strategy to Realize Therapeutic Cancer Vaccination
per: Markus Haug, et al.
Publicat: (2018-04-01)

Peptide Vaccine Therapy in Colorectal Cancer
per: Shi-Yu Yang, et al.
Publicat: (2012-08-01)

Peptide-Based Immunotherapeutics and Vaccines
per: Pedro A. Reche, et al.
Publicat: (2014-01-01)

Peptide-Based Vaccines for Tuberculosis
per: Wenping Gong, et al.
Publicat: (2022-01-01)

Potential association factors for developing effective peptide-based cancer vaccines
per: Chongming Jiang, et al.
Publicat: (2022-07-01)

Overlapping synthetic peptides as vaccines
per: Jiang, S, et al.
Publicat: (2006)

Computer-aided prediction of antigen presenting cell modulators for designing peptide-based vaccine adjuvants
per: Gandharva Nagpal, et al.
Publicat: (2018-07-01)

Peptide‐Based Cancer Vaccine Delivery via the STINGΔTM‐cGAMP Complex
per: He, Yanpu, et al.
Publicat: (2022)

Current Peptide and Protein Candidates Challenging HIV Therapy beyond the Vaccine Era
per: Koollawat Chupradit, et al.
Publicat: (2017-09-01)

Antigen presentation. Naturally processed peptides.
per: Elliott, T, et al.
Publicat: (1990)

Tolerogenic Immunomodulation by PEGylated Antigenic Peptides
per: Jennifer Pfeil, et al.
Publicat: (2020-10-01)

Beyond the vaccines: a glance at the small molecule and peptide-based anti-COVID19 arsenal
per: Kunal Nepali, et al.
Publicat: (2022-09-01)

1040-H Coupling DNA barcoding and multi-peptide screening: unveiling T cell receptor and antigenic peptide relationships in complex samples
per: Miranda Byrne-Steele, et al.
Publicat: (2023-11-01)

Synthetic peptide vaccines
per: O. V. Sergeyev, et al.
Publicat: (2016-02-01)

Peptide Vaccines for Leishmaniasis
per: Rory C. F. De Brito, et al.
Publicat: (2018-05-01)

Peptide-Based Immunotherapeutics and Vaccines 2017
per: Pedro Reche, et al.
Publicat: (2018-01-01)

Peptide-Based Immunotherapeutics and Vaccines 2015
per: Pedro Reche, et al.
Publicat: (2015-01-01)

Antitumor Peptide-Based Vaccine in the Limelight
per: Takumi Kumai, et al.
Publicat: (2022-01-01)

Editorial: Synthetic peptide vaccine platforms targeting tumor-specific antigens: advances and challenges
per: Reid M. Rubsamen, et al.
Publicat: (2024-02-01)

MHC-restricted antigen presentation and recognition: constraints on gene, recombinant and peptide vaccines in humans
per: Cunha-Neto E.
Publicat: (1999-01-01)

Light control of the peptide-loading complex synchronizes antigen translocation and MHC I trafficking
per: Jamina Brunnberg, et al.
Publicat: (2021-03-01)

Chaperone-mediated MHC-I peptide exchange in antigen presentation
per: Jiansheng Jiang, et al.
Publicat: (2024-05-01)

Molecular characterization of antigen-peptide pulsed dendritic cells: immature dendritic cells develop a distinct molecular profile when pulsed with antigen peptide.
per: Amy X Yang, et al.
Publicat: (2014-01-01)